|
|
|
Volumn 23, Issue 4, 1996, Pages 436-445
|
|
Critical evaluation of prognostic factors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DNA;
DNA TOPOISOMERASE (ATP HYDROLYSING);
GLUTATHIONE TRANSFERASE;
GLYCOPROTEIN P;
PROTEIN P53;
THYMIDYLATE SYNTHASE;
UROKINASE;
ANGIOGENESIS;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER RECURRENCE;
HISTOPATHOLOGY;
HUMAN;
LYMPH NODE METASTASIS;
ONCOGENE NEU;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
TUMOR VOLUME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
NEOPLASM METASTASIS;
ORGAN SPECIFICITY;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RISK ASSESSMENT;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0029846232
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (42)
|
|
References (0)
|
